(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted one of its private portfolio companies Evommune Inc raised USD150 million in its initial public offering. RTW Biotech, a London-listed ...
Third article in Paolo's Biotech Notes series. PDF attached and uploaded. Additionally, Paolo has provided a relevant timely article. ContraFect Corp (CFRX) has a promising pipeline with a potential ...
The micro-cap biotech, currently valued at just $7.46 million, has experienced significant stock volatility with shares down 89.52% over the past year, though recent weeks have shown a 20% recovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results